View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Service Listings   |   Industry News   |   Events
March 14, 2019
learn more
Newsletter Sponsor
   Our Capabilities Have Grown Broader But Our Focus Is As Clear As Ever

Since our founding in 1984, we greatly expanded our pharmaceutical development services. But through all the growth, we have not lost focus on our foundational services: supporting First-time-in-Man and Phase I projects. We continue to invest in equipment and resources to help customers navigate the unique challenges of these programs. Read more about how Metrics can support your project through different approaches to FTIM Studies.

more info

» Industry News
 
more news
» Featured Articles
Continuous Manufacturing is Gaining Steam, but Batch Processing Continues to be a Proven Alternative
Quite often viewed as the modern era in chemical manufacturing, continuous manufacturing has been gaining steam over the past few years as a means to manufacture drugs more efficiently, ensure safety ... read more »
The Agility Fallacy
The pharmaceutical industry has focused considerable effort on increasing organizational agility, particularly in terms of reducing cycle times and getting products to market faster. But too often ... read more »
more articles
 
» Featured Video
learn more
  Watch Video: Mark Egerton, CEO of Quotient Sciences, Interview at AAPS 2017
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial... read more »
learn more
  Watch Video: Pfanstiehl - Global Leader in Bioprocessing Solutions
Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical ... read more »

more videos
 
» Featured Whitepaper
Host Cell Protein Analysis in Biologic Drug Development
This whitepaper reviews fundamental aspects of HCPs that pertain to biologic drug development and presents current and emerging approaches to HCP ... read more »
Considerations for Development of a Lyophilized Biosimilar
The patents for a number of parental biologic formulations are destined to expire in the United States between 2016 and 2027. This provides ... read more »
more articles
 
| Events
EVENT
  ExL’s Proactive GCP Compliance
Philadelphia, PA –  03/18/2019
Now in its tenth year, ExL’s Proactive GCP Compliance conference continues to act as the annual forum for both senior-level clinical quality and ... event details »
EVENT
  BIO International Convention
Philadelphia, PA –  06/03/2019
As the world’s largest global biotechnology partnering event, the BIO International Convention (#BIO2019) is the one event where you can access 16,000... event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA